{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:37:49Z","timestamp":1792715869291,"version":"4.5.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04488-z","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:57:25Z","timestamp":1785218245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of neoadjuvant therapy with locoregional recurrence according to recurrence definitions in breast cancer: a retrospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Yoshiko","family":"Masuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuteru","family":"Yoshinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"4488_CR1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.20.03399","volume":"39","author":"LA Korde","year":"2021","unstructured":"Korde LA, Somerfield MR, Carey LA, et al. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. J Clin Oncol. 2021;39:1485\u2013505.","journal-title":"J Clin Oncol"},{"key":"4488_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1470-2045(17)30777-5","volume":"19","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2018","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer. Lancet Oncol. 2018;19:27\u201339.","journal-title":"Lancet Oncol"},{"key":"4488_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer. Lancet. 2014;384:164\u201372.","journal-title":"Lancet"},{"key":"4488_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1200\/JCO.2007.15.0326","volume":"26","author":"TA Buchholz","year":"2008","unstructured":"Buchholz TA, Lehman CD, Harris JR, et al. Locoregional treatments after preoperative chemotherapy for breast cancer. J Clin Oncol. 2008;26:791\u20137.","journal-title":"J Clin Oncol"},{"key":"4488_CR5","first-page":"79","volume":"42","author":"A Valachis","year":"2018","unstructured":"Valachis A, Nilsson C. Risk factors for locoregional disease recurrence after neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis. Breast. 2018;42:79\u201385.","journal-title":"Breast"},{"key":"4488_CR6","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1200\/JCO.19.02576","volume":"38","author":"M Morrow","year":"2020","unstructured":"Morrow M, Khan AJ. Locoregional management after neoadjuvant chemotherapy. J Clin Oncol. 2020;38:2281\u20139.","journal-title":"J Clin Oncol"},{"key":"4488_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/cncr.20815","volume":"103","author":"AM Chen","year":"2005","unstructured":"Chen AM, Meric-Bernstam F, Hunt KK, et al. Breast conservation after neoadjuvant chemotherapy. Cancer. 2005;103:689\u201395.","journal-title":"Cancer"},{"key":"4488_CR8","doi-asserted-by":"publisher","first-page":"103828","DOI":"10.1016\/j.breast.2024.103828","volume":"78","author":"JH Cheun","year":"2024","unstructured":"Cheun JH, Kwak Y, Kang E, et al. Locoregional recurrence after neoadjuvant versus adjuvant chemotherapy based on tumor subtypes. Breast. 2024;78:103828.","journal-title":"Breast"},{"key":"4488_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S1470-2045(13)70589-8","volume":"15","author":"S Aebi","year":"2014","unstructured":"Aebi S, Gelber S, Anderson SJ, et al. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial. Lancet Oncol. 2014;15:156\u201363.","journal-title":"Lancet Oncol"},{"key":"4488_CR10","first-page":"1873","volume":"39","author":"MJ van der Sangen","year":"2003","unstructured":"van der Sangen MJ, et al. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies. Eur J Cancer. 2003;39:1873\u20139.","journal-title":"Eur J Cancer"},{"key":"4488_CR11","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1200\/JCO.2017.75.5389","volume":"36","author":"HB Neuman","year":"2018","unstructured":"Neuman HB, Schumacher JR, Francescatti AB, et al. Risk of synchronous distant recurrence at time of locoregional recurrence in breast cancer. J Clin Oncol. 2018;36:975\u201382.","journal-title":"J Clin Oncol"},{"issue":"446","key":"4488_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496\u2013509.","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"4488_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivar Behav Res"},{"issue":"5","key":"4488_CR14","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/cancers17050766","volume":"17","author":"D Gentile","year":"2025","unstructured":"Gentile D, Canzian J, Barbieri E, Di Maria Grimaldi S, De Sanctis R, Tinterri C. Superior survival and lower recurrence outcomes with breast-conserving surgery compared to mastectomy following neoadjuvant therapy in 607 breast cancer patients. Cancers (Basel). 2025;17(5):766.","journal-title":"Cancers (Basel)"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04488-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04488-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04488-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:41:45Z","timestamp":1792712505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04488-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4488"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04488-z","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Fukuoka University Hospital (approval number: H26-04-005).Because this study used only existing clinical data and involved no intervention, the requirement for written informed consent was waived. An opt-out method was implemented.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"405"}}